Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer

G. Cserni, D. Gregori, F. Merletti, A. Sapino, M. P. Mano, A. Ponti, S. Sandrucci, B. Baltás, G. Bussolati

Research output: Contribution to journalArticle

Abstract

Background: The need for further axillary treatment in patients with breast cancer with low-volume sentinel node (SN) involvement (micrometastases or smaller) is controversial. Methods: Twenty-five studies reporting on non-SN involvement associated with low-volume SN involvement were identified using Medline and a meta-analysis was performed. Results: The weighted mean estimate for the incidence of non-SN metastases after low-volume SN involvement is around 20 per cent, whereas this incidence is around 9 per cent if the SN involvement is detected by immunohistochemistry (IHC) alone. Subset analyses suggest that studies with axillary dissection after any type of SN involvement result in somewhat higher estimates than studies allowing omission of axillary clearance, as do studies with more detailed histological evaluation of the SN compared with those with a less intensive histological protocol. Higher-quality papers yield lower pooled estimates than lower-quality papers. Conclusion: The risk of non-SN metastasis with a low-volume metastasis in the SN is around 10-15 per cent, depending on the method of detection of SN involvement. This should be taken into account when assessing the risk of omission of axillary dissection after a positive SN biopsy yielding micrometastatic or immunohistochemically positive SNs.

Original languageEnglish
Pages (from-to)1245-1252
Number of pages8
JournalBritish Journal of Surgery
Volume91
Issue number10
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Meta-Analysis
Breast Neoplasms
Neoplasm Metastasis
Dissection
cyhalothrin
Neoplasm Micrometastasis
Incidence
Immunohistochemistry
Biopsy

ASJC Scopus subject areas

  • Surgery

Cite this

Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. / Cserni, G.; Gregori, D.; Merletti, F.; Sapino, A.; Mano, M. P.; Ponti, A.; Sandrucci, S.; Baltás, B.; Bussolati, G.

In: British Journal of Surgery, Vol. 91, No. 10, 10.2004, p. 1245-1252.

Research output: Contribution to journalArticle

Cserni, G, Gregori, D, Merletti, F, Sapino, A, Mano, MP, Ponti, A, Sandrucci, S, Baltás, B & Bussolati, G 2004, 'Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer', British Journal of Surgery, vol. 91, no. 10, pp. 1245-1252. https://doi.org/10.1002/bjs.4725
Cserni, G. ; Gregori, D. ; Merletti, F. ; Sapino, A. ; Mano, M. P. ; Ponti, A. ; Sandrucci, S. ; Baltás, B. ; Bussolati, G. / Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. In: British Journal of Surgery. 2004 ; Vol. 91, No. 10. pp. 1245-1252.
@article{7bf150cc03bc43a4bb08131a7edfc33d,
title = "Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer",
abstract = "Background: The need for further axillary treatment in patients with breast cancer with low-volume sentinel node (SN) involvement (micrometastases or smaller) is controversial. Methods: Twenty-five studies reporting on non-SN involvement associated with low-volume SN involvement were identified using Medline and a meta-analysis was performed. Results: The weighted mean estimate for the incidence of non-SN metastases after low-volume SN involvement is around 20 per cent, whereas this incidence is around 9 per cent if the SN involvement is detected by immunohistochemistry (IHC) alone. Subset analyses suggest that studies with axillary dissection after any type of SN involvement result in somewhat higher estimates than studies allowing omission of axillary clearance, as do studies with more detailed histological evaluation of the SN compared with those with a less intensive histological protocol. Higher-quality papers yield lower pooled estimates than lower-quality papers. Conclusion: The risk of non-SN metastasis with a low-volume metastasis in the SN is around 10-15 per cent, depending on the method of detection of SN involvement. This should be taken into account when assessing the risk of omission of axillary dissection after a positive SN biopsy yielding micrometastatic or immunohistochemically positive SNs.",
author = "G. Cserni and D. Gregori and F. Merletti and A. Sapino and Mano, {M. P.} and A. Ponti and S. Sandrucci and B. Balt{\'a}s and G. Bussolati",
year = "2004",
month = "10",
doi = "10.1002/bjs.4725",
language = "English",
volume = "91",
pages = "1245--1252",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer

AU - Cserni, G.

AU - Gregori, D.

AU - Merletti, F.

AU - Sapino, A.

AU - Mano, M. P.

AU - Ponti, A.

AU - Sandrucci, S.

AU - Baltás, B.

AU - Bussolati, G.

PY - 2004/10

Y1 - 2004/10

N2 - Background: The need for further axillary treatment in patients with breast cancer with low-volume sentinel node (SN) involvement (micrometastases or smaller) is controversial. Methods: Twenty-five studies reporting on non-SN involvement associated with low-volume SN involvement were identified using Medline and a meta-analysis was performed. Results: The weighted mean estimate for the incidence of non-SN metastases after low-volume SN involvement is around 20 per cent, whereas this incidence is around 9 per cent if the SN involvement is detected by immunohistochemistry (IHC) alone. Subset analyses suggest that studies with axillary dissection after any type of SN involvement result in somewhat higher estimates than studies allowing omission of axillary clearance, as do studies with more detailed histological evaluation of the SN compared with those with a less intensive histological protocol. Higher-quality papers yield lower pooled estimates than lower-quality papers. Conclusion: The risk of non-SN metastasis with a low-volume metastasis in the SN is around 10-15 per cent, depending on the method of detection of SN involvement. This should be taken into account when assessing the risk of omission of axillary dissection after a positive SN biopsy yielding micrometastatic or immunohistochemically positive SNs.

AB - Background: The need for further axillary treatment in patients with breast cancer with low-volume sentinel node (SN) involvement (micrometastases or smaller) is controversial. Methods: Twenty-five studies reporting on non-SN involvement associated with low-volume SN involvement were identified using Medline and a meta-analysis was performed. Results: The weighted mean estimate for the incidence of non-SN metastases after low-volume SN involvement is around 20 per cent, whereas this incidence is around 9 per cent if the SN involvement is detected by immunohistochemistry (IHC) alone. Subset analyses suggest that studies with axillary dissection after any type of SN involvement result in somewhat higher estimates than studies allowing omission of axillary clearance, as do studies with more detailed histological evaluation of the SN compared with those with a less intensive histological protocol. Higher-quality papers yield lower pooled estimates than lower-quality papers. Conclusion: The risk of non-SN metastasis with a low-volume metastasis in the SN is around 10-15 per cent, depending on the method of detection of SN involvement. This should be taken into account when assessing the risk of omission of axillary dissection after a positive SN biopsy yielding micrometastatic or immunohistochemically positive SNs.

UR - http://www.scopus.com/inward/record.url?scp=4944233034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944233034&partnerID=8YFLogxK

U2 - 10.1002/bjs.4725

DO - 10.1002/bjs.4725

M3 - Article

C2 - 15376203

AN - SCOPUS:4944233034

VL - 91

SP - 1245

EP - 1252

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 10

ER -